Noom GLP-1 Program Review: Worth It? [2026]

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan.

Affiliate Disclosure: We may earn a commission if you sign up for services through our links. This does not affect our editorial independence.

---

Reviewed by The GLP-1 Guide Team | Last Updated: 2024

---

What Is the Noom GLP-1 Program?

Noom has been known since 2008 as a psychology-based weight loss app — the one with color-coded foods and daily lessons about cognitive behavioral therapy. In recent years, the company expanded into what it calls Noom Med, a telehealth service that connects users with licensed healthcare providers who can prescribe GLP-1 receptor agonist medications, including semaglutide (the active ingredient in Ozempic and Wegovy) and, in some markets, tirzepatide.

The result is the Noom GLP-1 program: a hybrid model that combines medication access with the behavioral coaching infrastructure Noom already had in place. The idea is straightforward — GLP-1 medications suppress appetite and slow gastric emptying, but they don't automatically teach you how to eat differently, handle emotional triggers, or maintain your progress if and when you stop the drug. Noom's pitch is that the coaching fills that gap.

This noom GLP-1 program review will walk through exactly what you get, what it costs, where it competes well, and where it falls short — based on publicly available program details, user-reported experiences, and the underlying clinical evidence for each component.

what-are-glp-1-medications-explained

---

How the Noom GLP-1 Program Works

Step 1: Eligibility Screening

Users start with an online health questionnaire covering current weight, medical history, previous weight loss attempts, and relevant conditions. Noom Med requires a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition (such as high blood pressure or type 2 diabetes) — which mirrors the FDA-approved eligibility criteria for semaglutide 2.4 mg (Wegovy).

A licensed provider reviews your responses and, if eligible, schedules a virtual visit or async consultation.

Step 2: Prescription and Medication Delivery

If approved, the healthcare provider writes a prescription. Noom works with compounding pharmacies to fulfill semaglutide prescriptions, which significantly reduces cost compared to brand-name Wegovy (which lists at approximately $1,349 per month without insurance as of 2024). Compounded semaglutide is not FDA-approved as a finished drug product — the FDA has flagged quality concerns with some compounding pharmacies — so this is worth discussing carefully with your provider.

Important context: The FDA has stated that compounded semaglutide drugs are not the same as FDA-approved Ozempic or Wegovy and are not subject to the same manufacturing oversight. Patients should ask their provider about the sourcing and quality controls of any compounded medication.

Medication is shipped directly to your home, typically within 5–10 business days after approval.

Step 3: Behavioral Coaching and App Features

This is where Noom distinguishes itself from pure medication platforms. Once enrolled, users get access to:

• Daily lessons built on cognitive behavioral therapy (CBT) and psychology principles — the same curriculum Noom has used since its early days
• A personal goal specialist (coach) reachable via in-app messaging
• Food logging with Noom's color-coded system (green, yellow, orange foods) calibrated to caloric density
• Progress tracking including weight, habits, and weekly check-ins
• Group support communities within the app

The coaching is asynchronous by default — you message your coach, and they respond within a window (typically within 24 hours on business days). This is different from a scheduled one-on-one video call, which some users prefer.

Step 4: Dose Escalation and Ongoing Provider Check-Ins

Semaglutide is typically started at a low dose (0.25 mg per week) and gradually increased over several months to minimize side effects. Noom's medical team handles dose adjustments through follow-up consultations built into the program. Users report check-ins approximately monthly, though the frequency may vary by plan tier and individual need.

semaglutide-dosing-schedule-what-to-expect

---

Noom GLP-1 Pricing Breakdown

Pricing is one of the most common questions in any noom med review — and for good reason. The cost structure has multiple layers.

What You'll Pay

Noom's GLP-1 program pricing as of 2024 breaks down roughly as follows:

Component	Estimated Monthly Cost
Noom behavioral coaching app (Med plan)	$49–$79/month
Compounded semaglutide (starting dose)	$99–$200/month
Compounded semaglutide (maintenance dose)	$150–$350/month
Provider consultations (often bundled)	Usually included
Estimated total range	$149–$429/month

These are estimates based on publicly available information and reported user costs. Prices vary based on plan selection, dose, and geographic location. Noom periodically runs promotions, particularly on the coaching subscription component.

How This Compares to Brand-Name GLP-1 Medications

Brand-name Wegovy (semaglutide 2.4 mg) has a list price of approximately $1,349 per month in the United States as of 2024, according to GoodRx data. Without insurance coverage, this is cost-prohibitive for most patients. With insurance, copays vary widely — some covered plans bring the cost to under $50/month, while others remain in the hundreds.

Noom's compounded semaglutide route is significantly cheaper, though it comes with the regulatory caveats noted above.

Insurance Coverage

Noom Med does not accept insurance for the medication or subscription cost. However, some users have had success using HSA or FSA funds for eligible expenses. Always verify with your benefits administrator before assuming coverage.

does-insurance-cover-glp-1-medications

---

What We Liked About the Noom GLP-1 Program

1. Behavioral Coaching Is a Real Differentiator

Most telehealth GLP-1 platforms are essentially prescription pipelines. You fill out a form, a provider approves you, medication arrives. There's no structured support for what happens between doses.

Noom's behavioral coaching infrastructure is genuinely more developed than most competitors. The daily lessons, CBT-based curriculum, and accessible coach model are things Noom has refined over more than a decade. According to a 2016 study published in Scientific Reports, Noom's app-based intervention was associated with weight loss in 77.9% of users who engaged with the program over an 18-month period — though this predates the GLP-1 integration and has limitations as self-selected user data.

The logic holds up clinically: research published in Obesity (2021) found that behavioral interventions combined with GLP-1 therapy produced better long-term maintenance outcomes than medication alone in some study populations.

2. All-in-One Platform Experience

Having medication management, coaching, food logging, and progress tracking in one app reduces friction. Users don't have to juggle a separate telehealth platform for prescriptions and another app for habit tracking. For people who struggle with health app fatigue, this consolidation is meaningful.

3. Medication Cost Is More Accessible Than Brand-Name Options

At $149–$429/month, the Noom GLP-1 program is substantially more affordable than paying out of pocket for brand-name Wegovy. For people without insurance coverage for weight management medications — which as of 2023, the majority of employer-sponsored health plans still excluded — this cost difference is significant.

4. Structured Dose Management

The built-in escalation protocol and regular provider check-ins mean users aren't left to figure out dose timing on their own. For a medication class where side effects (nausea, vomiting, constipation) are most pronounced at the wrong dose, this structure has real safety value.

---

What Could Be Better

1. Compounded Medication Carries Regulatory Risk

This is the most significant concern in any honest noom ozempic program review. Noom uses compounding pharmacies to supply semaglutide rather than the FDA-approved brand-name formulations. In 2024, the FDA removed semaglutide from its drug shortage list, which triggered regulatory changes that may affect the legal status of compounded semaglutide from 503A and 503B pharmacies going forward.

This is an evolving situation. Patients should discuss sourcing, accreditation, and quality controls with their Noom provider — and stay informed about FDA guidance updates.

2. Coaching Quality Is Inconsistent

Multiple user reviews across platforms (Reddit's r/Noom, Trustpilot, the App Store) describe wide variation in coach responsiveness and quality. Some users report coaches who send personalized, thoughtful responses. Others describe feeling like they received generic, template-style messages. This is a known challenge with app-based coaching at scale.

Noom does not appear to publish specific credentials for goal specialists — they are not clinical dietitians or licensed therapists by default. Users who need clinical-level nutritional or psychological support may need to seek that separately.

3. The App Can Feel Overwhelming

The daily lessons, food logging, coaching messages, and check-in reminders create a high-engagement demand. For users who are managing medication side effects (particularly in the first few weeks of semaglutide), keeping up with app requirements can feel burdensome. Some users report dropping off the behavioral program entirely while managing nausea, which may reduce the long-term benefit of the coaching component.

4. No Insurance Billing

The inability to run costs through insurance — even partially — is a real limitation for cost-sensitive users. Competitors like Found and some telehealth platforms are beginning to work with insurance partners. Noom's all-cash model limits accessibility for a population where cost is often the primary barrier.

5. Limited Transparency on Provider Credentials and Processes

Noom does not make it easy to find specific information about which states it operates in, the credentials of its prescribing providers, or detailed quality standards for its pharmacy partners. Prospective users need to ask these questions directly during the intake process.

---

Noom GLP-1 vs. Competitors: How It Stacks Up

The table below compares Noom Med against several major GLP-1 telehealth platforms based on publicly available information as of 2024. Prices are estimates and subject to change.

Platform	Key Feature	Est. Monthly Cost	Medication Type	Coaching Included?	Best For
Noom Med	Behavioral coaching + CBT app	$149–$429	Compounded semaglutide	✅ Yes (app-based)	Users who want structured habit support
Ro Body	Telehealth + compounded GLP-1	$145–$297	Compounded semaglutide	Limited (check-ins only)	Streamlined prescription access
Hims & Hers	Low-cost telehealth entry	$199–$299	Compounded semaglutide	❌ Minimal	Cost-conscious users, basic access
Found	Medication + coaching + community	$99–$199 (+ med cost)	Compounded or brand-name	✅ Yes (coach + community)	Holistic program seekers
WeightWatchers Clinic	Points program + GLP-1 access	$84–$199 (+ med cost)	Varies by state	✅ Yes (WW program)	Existing WW users
Direct brand-name (Wegovy)	FDA-approved formulation	$1,349/month (list)	FDA-approved semaglutide	❌ None included	Patients with insurance coverage

Key takeaway from this table: Noom Med sits in the mid-to-upper price range for GLP-1 telehealth platforms, but it offers more structured behavioral support than most. If cost is your primary concern, Hims & Hers or Ro may be more accessible. If you want the most clinically validated medication, working with your primary care provider to access brand-name Wegovy through insurance is the most direct path.

---

Who Is the Noom GLP-1 Program Best For?

Not every weight management platform works the same way for every person. Here's an honest breakdown of who tends to get the most value from Noom's approach.

This Program Works Well For:

• People who know medication alone won't be enough. If you've tried restriction-based diets before and found that behavior patterns — emotional eating, late-night snacking, stress responses — were the real obstacle, the coaching component may address something that a prescription alone doesn't.
• Users who are comfortable with app-based engagement. Noom's model requires daily interaction with the app to get full value. If you find habit-tracking apps motivating rather than stressful, this format will suit you.
• Those without insurance coverage for GLP-1 medications. The compounded semaglutide route makes medication access significantly cheaper than brand-name alternatives, and the bundled coaching means you're getting more than just a prescription.
• People in the early stages of their weight management journey who want a structured program rather than figuring out GLP-1 side management, dose escalation, and behavior change independently.

This Program May Not Be the Right Fit If:

• You need clinical-level dietary or psychological support. Noom's coaches are not registered dietitians or licensed therapists by default. If you have complex nutritional needs, an eating disorder history, or significant mental health considerations related to weight, working with specialized clinical providers is more appropriate.
• You're already established on a brand-name GLP-1 with insurance coverage. If Wegovy or Zepbound is covered by your insurance at a reasonable copay, there's no cost advantage to switching to Noom's compounded option.
• You prefer minimal app interaction. Noom's value proposition is built on daily engagement. If that model has burned you out before, a simpler telehealth prescription service may be more sustainable.
• You're concerned about the regulatory status of compounded semaglutide. Given evolving FDA guidance, some patients prefer to wait for clarity or work through channels that prescribe FDA-approved formulations.

glp-1-telehealth-platforms-compared

---

Frequently Asked Questions

Is Noom Med the same as getting an Ozempic prescription?

No. Noom Med prescribes compounded semaglutide through partner pharmacies, not FDA-approved Ozempic or Wegovy. Compounded semaglutide contains the same active ingredient but is not manufactured or regulated the same way as brand-name drugs. Ozempic is FDA-approved for type 2 diabetes; Wegovy is FDA-approved for chronic weight management. Compounded versions are produced by specialized pharmacies and may vary in formulation quality. Always ask your provider about the specific compounding pharmacy and its accreditation.

How much weight can I expect to lose on the Noom GLP-1 program?

Individual results vary significantly and depend on starting weight, dose, adherence to behavioral coaching, diet, and physical activity. The STEP 1 clinical trial (2021, New England Journal of Medicine) found that participants on semaglutide 2.4 mg lost an average of 14.9% of body weight over 68 weeks compared to 2.4% for placebo. Noom does not publish its own separate clinical outcome data for the combined medication-plus-coaching program. No specific weight loss outcome can be guaranteed.

Does Noom accept insurance for the GLP-1 program?

As of 2024, Noom Med does not accept insurance for its medication or subscription costs. Some users may be able to use HSA or FSA funds for eligible medical expenses — check with your plan administrator. For those with insurance coverage for GLP-1 medications, working directly with your primary care provider or endocrinologist to access brand-name coverage through your insurer may be more cost-effective.

What happens if I want to stop the medication?

Research published in Diabetes, Obesity and Metabolism (2022) found that participants who stopped semaglutide regained approximately two-thirds of their lost weight within one year after discontinuation. This is why Noom emphasizes behavioral coaching as a long-term strategy — the goal is to establish habits that support weight maintenance even if medication is eventually tapered or stopped. Talk to your healthcare provider before changing your medication regimen.

Is the Noom GLP-1 program available in all U.S. states?

Noom Med is not available in all states due to varying telehealth prescribing regulations. Availability may also change as regulations evolve. The most accurate way to check is to begin Noom's intake process, which will confirm eligibility based on your location. As of 2024, Noom Med is available in a significant majority of U.S. states but not universally.

---

Methodology and Sources

This review is based on:

• Publicly available program information from Noom's website and enrollment process as of 2024
• Clinical trial data from peer-reviewed publications, including the STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) and related GLP-1 outcome studies
• FDA guidance documents on compounded semaglutide and GLP-1 drug shortage status (FDA.gov, 2023–2024)
• User-reported experiences from public forums including Reddit (r/Noom, r/Semaglutide), Trustpilot, and the Apple App Store — noted as anecdotal and not representative of all users
• Pricing data from GoodRx, platform websites, and user-reported costs — all pricing is approximate and subject to change
• Competitor program research conducted through direct review of platform websites and publicly available enrollment information

We do not receive payment from Noom or any competitor to influence the editorial content of this review. Where affiliate relationships exist, they are disclosed at the top of this article.

---

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. GLP-1 medications carry risks including gastrointestinal side effects, rare but serious risks such as pancreatitis and thyroid tumors (observed in animal studies), and interactions with other medications. A licensed provider should evaluate your full medical history before prescribing.

Affiliate Disclosure: We may earn a commission if you sign up for services through our links. This does not affect our editorial independence or the integrity of our reviews.

side-effects-of-semaglutide-what-to-know

---

-- The GLP-1 Guide Team

`